Supply Chain

The FDA will end a program that allowed devicemakers to conceal reports of device-related harm and malfunctions from the public and physicians, according to Kaiser Health News.

The FDA must close loopholes and uphold higher safety standards when screening, approving and monitoring medical devices, The New York Times editorial board wrote in an opinion piece on May 4.

In a recent Becker’s Hospital Review article, a stark truth was stated: A hospital system procures everything and makes nothing.

As costs continue to go up while reimbursements go down, hospitals and health systems are looking for new ways to control expenses without affecting the quality of care. One strategy that continues to gain momentum is standardization.

Philadelphia-based Nazareth Hospital has launched an internal investigation after $25,000 worth of endoscopes were stolen in April, according to CBS Philadelphia.

Five drugs or medical devices have been approved by the FDA since April 26:

The FDA will not ban the sale and use of textured breast implants linked to a rare cancer, despite recent concerns over the safety of the product.

Ensuring optimal skin health outcomes while also lowering cost per case poses several challenges for healthcare organizations, especially given the increasing need of skin and wound care, increasing complexity of wound care management, and the industry's changing reimbursement structure.

Merck has increased production of the measles vaccine to meet growing demand amid the country's largest outbreak in 25 years, according to Reuters.

As declining reimbursements and increasing product expenses cut into hospital margins, providers are constantly seeking new ways to control costs without compromising patient care.